Is alanine aminotransferase (ALT) a specific blood marker of hepatocellular injury?

Alanine aminotransferase (ALT) is one of the most frequently utilized biomarkers in clinical practice for assessing liver health. Primarily concentrated in the cytoplasm of hepatocytes, its presence in the bloodstream serves as a specific indicator of hepatic integrity and function.

Clinical utility and specificity

ALT is the primary screening tool for identifying hepatocellular damage across a wide range of conditions, including viral hepatitis, non-alcoholic fatty liver disease (NAFLD), and drug-induced liver injury.

• Hepatocyte Specificity: ALT possesses high hepatocyte specificity (95–100%), making it more indicative of liver-specific damage than other enzymes like aspartate aminotransferase (AST), which is also found in muscle and heart tissue.
• Thresholds and Guidelines: Clinical guidelines from the American Association for the Study of Liver Diseases (AASLD) emphasize that even minor elevations—often defined as levels exceeding 19–25 U/L for women and 29–33 U/L for men—can signal underlying pathology.
• Correlation with Injury: Serum ALT levels correlate strongly with the extent of liver necrosis (Pearson’s r = 0.836), providing a quantitative measure of the severity of the insult.

Mechanistic explanations

The release of ALT into the serum is a direct result of hepatocyte membrane compromise.

• Membrane Permeability: In scenarios of hepatocellular stress or reversible injury, increased membrane permeability or "blebbing" allows cytoplasmic ALT to leak into the plasma without necessarily resulting in cell death.
• Necrotic Release: During acute necrosis (e.g., toxic insult or ischemia), the hepatocyte membrane ruptures completely, leading to a passive and significant efflux of the enzyme into the systemic circulation.
• Cytoplasmic Localization: Because ALT resides in the cytoplasm rather than the mitochondria, it is often released early in the course of liver injury, making it a sensitive marker for acute changes.

Bottom line

ALT is a robust and highly specific biomarker for hepatocellular injury. Its elevation in the blood directly reflects hepatocyte membrane leakage or rupture, providing essential clinical insight into the presence and degree of liver stress or damage.